In colorectal cancer, RASAL2 interacts with Hippo regulator LATS2, preventing YAP from degradative ubiquitination and thereby enabling its oncogenic function as a nuclear transcription co-factor [11]. Here, RASAL2 is linked to colorectal cancer.